Home Covid-19 SEHA’s new field clinic in Abu Dhabi to accept walk-in registrations for Covid-19 vaccine volunteers Health authorities in the UAE have issued a permit for up to 15,000 volunteers to take part in the Phase III trials by Varun Godinho August 3, 2020 The Department of Health Abu Dhabi in collaboration with G42 Healthcare and Abu Dhabi Health Services (SEHA) have opened a new field clinic at ADNEC to facilitate the Phase III Covid-19 vaccine trials that are underway within the country. The new facility will accept walk-in registrations and will also serve as a testing facility for volunteers who want to participate in the world’s first clinical Phase III trial of an inactivated vaccine for Covid-19, reported news agency WAM. The trials are open to healthy volunteers who are residents of Abu Dhabi and aged between 18-60. .@DoHSocial, in cooperation with G42 Healthcare and @SEHAHealth has opened a specialised field clinic at @ADNECGroup to register, examine and select volunteers wishing to participate in the world’s first clinical trial for the 3rd phase of inactive vaccine for the Covid-19 virus. — مكتب أبوظبي الإعلامي (@admediaoffice) August 2, 2020 The testing period will extend between six to eight months, with volunteers required to be available for follow ups during this time. The field clinic is able to accommodate 1,000 volunteers per day. Those who wish to volunteer can visit the clinic without prior appointment or registration, seven days a week from 8am-8pm. Volunteers will receive on-site Covid-19 screening. The first vaccination will be administered to those who are eligible three days after they test negative for Covid-19. افتتحت دائرة الصحة أبوظبي بالتعاون مع جي 42 للرعاية الصحية وشركة أبوظبي للخدمات الصحية (صحة) عيادة ميدانية متخصصة بمركز أبوظبي الوطني للمعارض لتسجيل وفحص واختيار المتطوعين الراغبين بالمشاركة في أول تجربة سريرية على مستوى العالم للمرحلة الثالثة من اللقاح غير النشط لفيروس كوفيد-19. pic.twitter.com/39I5lN91tB — مكتب أبوظبي الإعلامي (@admediaoffice) August 2, 2020 The Phase III trials commenced on July 16 with Sheikh Abdullah bin Mohammed Al Hamed, chairman of the Department of Health – Abu Dhabi (DOH), becoming the very first volunteer. Read: Head of Abu Dhabi’s health department becomes first volunteer for Covid-19 Phase III vaccine trials The trials are being conducted as a partnership between Abu Dhabi based G42 Healthcare, and Sinopharm CNBG, the world’s sixth largest vaccine manufacturer. Health authorities in the UAE have issued a permit for up to 15,000 volunteers to take part in the trials. The phase III clinical trial follows the success of the phase I and phase II trials conducted by Sinopharm in China, which resulted in 100 per cent of the volunteers generating antibodies after two doses in 28 days. The Abu Dhabi Media Office added that further details about the volunteer registration programme can be found online at 4humanity.ae Tags Abu Dhabi Health Services Covid-19 Covid-19 Vaccine Trials Department of Health Abu Dhabi G42 Healthcare Healthcare Phase III Covid-19 vaccine SEHA Sinopharm CNBG UAE 0 Comments You might also like Insights: How UAE is enabling network transformation in the AI age NielsenIQ H1 report reveals region’s split shopper preferences UAE’s Rebound launches subscription-based recycling platform UAE, Jordan sign $2.3bn agreement to build railways